A 50mg mass unit of Sermorelin represents a high-yield configuration designed for automated cell culture, high-throughput receptor assays, and large-scale preclinical study protocols. This reference guide outlines the chemical specification, precise reconstitution calculations across various diluent volumes, and analytical quality standards for managing high-concentration GHRH fragment workflows.
A 50mg mass unit of Sermorelin represents a high-yield configuration designed for automated cell culture, high-throughput receptor assays, and large-scale preclinical study protocols. This reference guide outlines the chemical specification, precise reconstitution calculations across various diluent volumes, and analytical quality standards for managing high-concentration GHRH fragment workflows.
Sermorelin (GRF 1-29 amide) is a synthetic 29-amino acid peptide corresponding to the amino-terminal segment of endogenous Growth Hormone-Releasing Hormone (GHRH). When supplied in a 50mg vial size, the compound provides a concentrated batch quantity intended primarily for laboratories conducting high-density in vitro testing, multi-plate receptor binding screens, or long-term comparative animal model studies where lot uniformity across extended experimental runs is critical.
While standard catalog items frequently feature smaller unit masses such as 2mg or 5mg, high-volume research initiatives often utilize the 50mg format to minimize batch-to-batch analytical variation. Investigators seeking standard laboratory quantities can explore the default catalog offering via the Sermorelin product page or inspect the full catalog of research compounds through all peptides. For custom high-yield bulk specifications like 50mg, PX1 Research facilitates tailored lot production under identical ISO 17025 analytical oversight.
Sermorelin consists of the sequence Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-NH2, representing the fully functional catalytic core of naturally occurring GHRH(1-44). Preclinical studies indicate that this truncated sequence retains full receptor affinity and biological activity at the GHRH receptor (GHRH-R), a Class B G-protein coupled receptor expressed on pituitary somatotropes.
In vitro binding assays demonstrate that ligand binding to GHRH-R activates adenylate cyclase via Gs alpha subunit signaling, driving intracellular cyclic adenosine monophosphate (cAMP) accumulation and downstream protein kinase A (PKA) cascade activity. Research models evaluating somatotroph cell lines confirm that this pathway regulates the transcription and pulsatile secretion of growth hormone without disrupting native feedback loops involving somatostatin.
Reconstituting a 50mg vial requires precise volumetric planning due to the substantial mass of active peptide involved. The target concentration per microliter (µg/µL or mg/mL) dictates the volume of sterile diluent—such as Bacteriostatic Water (0.9% benzyl alcohol) or sterile physiological saline—added to the lyophilized cake. Researchers can utilize the interactive reconstitution calculator to verify custom dilution series prior to laboratory execution.
When adding 1.0 mL of diluent to a 50mg cake, the resulting solution yields a final concentration of 50.0 mg/mL (50.0 µg/µL). Adding 2.0 mL yields 25.0 mg/mL (25.0 µg/µL), while 3.0 mL yields 16.67 mg/mL (16.67 µg/µL). For micro-pipetting accuracy in cellular assays requiring lower working stocks, adding 5.0 mL or 10.0 mL produces 10.0 mg/mL (10.0 µg/µL) and 5.0 mg/mL (5.0 µg/µL), respectively. Diluent should be introduced along the glass vial wall slowly to avoid turbulent agitation and foam formation, which can induce physical shear stress and peptide aggregation.
High-mass vials present unique handling considerations regarding freeze-thaw degradation. Once reconstituted, aqueous peptide solutions are vulnerable to hydrolysis, methionine oxidation at position 27, and surface adsorption. To maintain chemical integrity, reconstituted 50mg stock solutions must be immediately sub-aliquoted into single-use polypropylene micro-centrifuge tubes or cryogenic vials within an aseptic laminar flow cabinet.
Lyophilized Sermorelin remains stable at -20°C for up to 24 months when protected from light and moisture. Following reconstitution, aliquoted working solutions should be stored at -80°C for long-term storage or 2°C to 8°C if utilized within 48 to 72 hours. Repeated freeze-thaw cycles must be rigorously avoided, as phase transitions accelerate peptide aggregation and reduce measured bioactivity in cell culture models.
Every batch of Sermorelin produced for PX1 Research undergoes rigorous analytical testing in ISO 17025 accredited facilities located in the USA. High-Performance Liquid Chromatography (HPLC) is employed to confirm chemical purity, maintaining a strict baseline standard of ≥98.0% area under the curve. Mass Spectrometry (MS) via electrospray ionization verifies absolute molecular weight against theoretical values (3357.9 Da), ensuring the absence of truncated sequences or synthesis impurities.
Because large-mass vials are frequently deployed in cellular and animal model research, endotoxin levels are evaluated using quantitative chromogenic Limulus Amebocyte Lysate (LAL) assays. PX1 Research mandates endotoxin thresholds below 0.01 EU/mg to prevent confounding inflammatory responses in sensitive biological assays. Researchers can inspect lot-specific data sheets directly via the COA portal.
In secretagogue and somatotrophic research, Sermorelin is frequently evaluated alongside other synthetic peptides that alter pituitary output. While Sermorelin represents the exact functional fragment of native GHRH with a short biological half-life, modified analogs such as CJC-1295 incorporate structural substitutions (e.g., D-Ala2, Gln8, Ala15, Leu27) that extend plasma stability and receptor binding kinetics. Alternatively, ghrelin receptor agonists like GHRP-2 and GHRP-6 operate through distinct Growth Hormone Secretagogue Receptors (GHS-R1a), providing researchers with complementary mechanisms for comparative signaling studies.
Selecting between native sequence GHRH fragments like Sermorelin and long-acting or GHS-R agonists depends on whether the experimental model targets physiological pulsatile dynamics or sustained receptor activation. Comparative study designs frequently utilize Sermorelin as a baseline control for non-sustained GHRH-R stimulation.
Determining whether to deploy a single 50mg vial versus multiple 2mg or 5mg units depends entirely on assay scale, pipetting automation, and target concentration. Standard 2mg or 5mg vials are generally preferred for small-scale assays or exploratory bench work, as smaller working volumes minimize the risk of solution degradation over extended testing windows.
Conversely, high-throughput automated platforms (e.g., 384-well microplate screening systems) or multi-subject preclinical rodent cohorts benefit significantly from 50mg configurations. Utilizing a single lot-matched 50mg vial eliminates inter-vial reconstitution variance across expansive microplates, ensuring uniform baseline peptide delivery. For custom high-volume allocations or institutional procurement inquiries, researchers can reference our wholesale information channel.
For cell culture and biochemical assay applications, proper buffer selection is required to maintain protein stability and target binding efficiency. Reconstitution in plain sterile water or saline is appropriate for initial stock generation, but subsequent dilutions into culture media (e.g., DMEM or RPMI) must account for ionic strength and pH balance. Sermorelin demonstrates optimal solubility and stability in slightly acidic to neutral pH environments (pH 6.0–7.4).
In low-concentration assay conditions (<1 µg/mL), non-specific adsorption of peptide to glass or polystyrene container walls can reduce effective concentrations. To mitigate wall binding, researchers should include a non-interfering carrier protein such as 0.1% Bovine Serum Albumin (BSA) or standard assay buffer salts once primary reconstitution is complete. Broader details on peptide properties and experimental design are available in our research library.
PX1 Research delivers verified, high-purity research compounds synthesized in USA-based, GMP-compliant manufacturing facilities. Each production lot undergoes strict quality control protocols from raw material peptide synthesis through final lyophilization and vial sealing under inert argon atmospheres.
By enforcing mandatory third-party COAs for every fill size, PX1 Research guarantees that all material delivered to academic, institutional, and private laboratories meets demanding quantitative purity, identity, and safety specifications. All standard catalog items ship same-day from distribution centers in California and Arizona when ordered Monday through Friday.
What is the primary benefit of ordering a 50mg Sermorelin vial?
A 50mg mass unit allows high-throughput research laboratories to maintain lot consistency across large-scale cell culture or preclinical animal studies, reducing variable baseline factors associated with opening multiple smaller vials.
Does PX1 Research offer Sermorelin in 50mg vials as a standard catalog item?
PX1 Research provides Sermorelin in standard catalog sizes such as 2mg and 5mg for immediate purchase. 50mg vials and custom high-yield bulk fill options are available upon request for high-volume research accounts through our wholesale division.
How should a 50mg Sermorelin vial be reconstituted for high-throughput assays?
The reconstitution volume depends on the required working concentration. For example, adding 2.0 mL of sterile diluent produces a 25.0 mg/mL solution, while 5.0 mL produces a 10.0 mg/mL solution. Diluent should be introduced gently down the inner glass wall to prevent foam formation.
What diluents are recommended for laboratory reconstitution of Sermorelin?
Bacteriostatic Water (0.9% benzyl alcohol) or Sterile Bacteriostatic Saline is recommended for multi-use stock solutions stored up to 28 days under refrigeration. For immediate single-day cell assays, sterile Water for Injection or phosphate-buffered saline (PBS) may be utilized.
How should reconstituted Sermorelin stock solutions be stored?
After reconstitution, stock solutions should be immediately sub-aliquoted into single-use micro-tubes to prevent repeated freeze-thaw cycles. Aliquots should be stored at -80°C for long-term preservation or 2°C to 8°C for short-term use (48–72 hours).
What purity levels are guaranteed for Sermorelin research materials?
Every lot of Sermorelin is verified by third-party HPLC and MS testing to meet or exceed ≥98.0% analytical purity. Detailed purity profiles, mass spec curves, and endotoxin levels (<0.01 EU/mg) are available via lot-matched Certificates of Analysis.
How does Sermorelin differ structurally from full-length GHRH(1-44)?
Sermorelin represents the truncated 29-amino acid N-terminal sequence (GRF 1-29) of human GHRH. Preclinical studies demonstrate that this 29-amino acid chain contains the full biological activity and GHRH-R binding affinity of the complete 44-amino acid protein.
Is Sermorelin 50mg suitable for human or veterinary administration?
No. All products supplied by PX1 Research are strictly intended for laboratory research, in vitro experiments, and preclinical animal models. They are not cleared or intended for human consumption, clinical use, or veterinary application.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.